-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Trevi Therapeutics (TRVI)
-
-
-
-
-
-
-
Trevi Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
-
-
-
-
-
-
-
Trevi Therapeutics to Present at H.C. Wainwright Global Investment Conference
-
21,798 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

